Cargando…
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
BACKGROUND: Randomised controlled trials (RCTs) of psilocybin have reported large antidepressant effects in adults with major depressive disorder and treatment-resistant depression (TRD). Given psilocybin's psychedelic effects, all published studies have included psychological support. These ef...
Autores principales: | Husain, Muhammad Ishrat, Blumberger, Daniel M., Castle, David J., Ledwos, Nicole, Fellows, Elise, Jones, Brett D. M., Ortiz, Abigail, Kloiber, Stefan, Wang, Wei, Rosenblat, Joshua D., Mulsant, Benoit H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375870/ https://www.ncbi.nlm.nih.gov/pubmed/37489299 http://dx.doi.org/10.1192/bjo.2023.535 |
Ejemplares similares
-
A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol
por: Husain, M. I., et al.
Publicado: (2023) -
Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023) -
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
por: Jones, Brett D. M., et al.
Publicado: (2021) -
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
por: Corrigan, Kate, et al.
Publicado: (2021) -
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)